It differs from the ADCS-CGIC used in AD trials mainly in its shorter length and its The CGIC rating is made on a 7-point Likert-type scale where change from. Characteristics and performance of a modified version of the ADCS-CGIC CIBIC+ in Alzheimer Disease Assessment Scale-cognitive, Activities of Daily Living. A mandate of the ADCS is to develop optimal assessment instruments for use in Living (ADL), and the Clinical Global Impression of Change Scale (CGIC).

Author: Tegis Vilkree
Country: Anguilla
Language: English (Spanish)
Genre: Literature
Published (Last): 2 November 2011
Pages: 261
PDF File Size: 11.11 Mb
ePub File Size: 8.84 Mb
ISBN: 353-3-83663-790-5
Downloads: 27366
Price: Free* [*Free Regsitration Required]
Uploader: Vicage

NTB domains Change in memory domain score i. The CGICs behaved as expected, showing no overall change over 3 months, no difference between administrations at home compared with clinics, and concurrent validity.

No adjustments for multiple comparisons were made given the exploratory nature of the hypotheses. We used a generalized scape equations approach for ordinal outcome data to test the effects of adcscgic, baseline characteristics and change in clinical measures on the MCI-CGIC over 12 months, and ordinal logistic regression to assess the association between MCI-CGIC and change in clinical measures at 6 months and 12 months.

The results from the two modeling approaches had clinically adcs–cgic effects, although the statistical significance differed. Cognitive-domain scores for memory the ADAS-cog immediate and delayed word-recall scores and the NYU immediate and delayed paragraph-recall scoresexecutive function the digits-backward test, Symbol Digit Modalities Test, and number-cancellation testlanguage the Boston Naming Test and adcs-cfic testand visuospatial skills the clock-drawing test were calculated in addition to an overall composite cognitive-function score.

Some subjects tended to rate themselves better than their partners rated them. Because very few change scores were at the extreme ratings of marked worsening, moderate worsening, marked improvement, or moderate improvement, we evaluated the rate of change of MCI-CGIC using adcz-cgic models.

The authors of the six month trial suggest that the lack of treatment differences might be due to the impact of MCI primarily on a single domain memory within the CGIC. AU – Doody, Rachelle S.

The co-primary, which compliments a significant difference between drug and placebo on a psychometric test, helps to determine the clinical significance of psychometric test differences for regulatory purposes. Although a common approach of analyzing CGIC in clinical trials has been to treat the variable as a continuous outcome, we chose to use the CGIC as an ordinal outcome and take advantage of the ordinal models that are available for such data such as the GEE rather than simply analyzing an ordinal outcome as a continuous outcome.


One objective adcs-ctic to develop self-rated and study partner-rated CGICs optimized for nondemented elderly or people with very early Alzheimer disease.

The dependent variable in the model was the MCI-CGIC scores over 12 months and the independent variables included change in secondary measures as a time varying covariatea time factor 6 and 12 monthsand the secondary adca-cgic by time interaction.

Alzheimer’s Disease and Associated Disorders. An inventory to assess activities of daily living for clinical trials in Alzheimer’s disease.


Adcs-cgif N, et al. Table 4 Treatment effect sizes at 6 and 12 months: Author information Copyright and License information Disclaimer. Open in a separate window. We assessed feasibility for its use by determining whether or not: Mild cognitive impairment, Alzheimer’s disease, dementia, global impression of change, rating scales, donepezil, vitamin E, clinical trials.

Variables at screening or baseline that were associated with worse CGIC scores over 6 and 12 months included white race, greater years of education, worse depression, dementia severity rating, cognitive, and daily activities scores, and lower memory domain scores on a neuropsychological battery.

ADCS Instruments – ADCS

One advantage is that the logistic link function specification takes into account the ceiling and floor effects of the dependent variable, the CGIC, while the linear models do not Morris reports that neither he nor his family own stock or have equity interest outside of mutual funds or other externally directed accounts in any pharmaceutical or biotechnology company; that from July to the present he has participated or is currently participating in clinical trials of antidementia drugs sponsored by Elan, Eli Lilly and Company, and Wyeth; and from January to the present has served as a consultant or has received speaking honoraria from Bristol-Myers Squibb, Elan, GE Healthcare, Genworth, Janssen-Cilag, Merck, Myriad, Neurochem, Neuroptix, and Schering-Plough.


Winship C, Mare RD. Criteria used by drug regulatory authorities. A practical method for grading the cognitive state of patients for the clinician.

ADRC – CGIC page

Thus, this study provides the first systematic evidence that CGIC ratings, at least in MCI patients, are based on more than assessments of memory. The ADCS-CGIC is a systematic method for assessing clinically significant change in a clinical trial as viewed by an independent skilled and experienced clinician.

The dependent variable in the model was the MCI-CGIC scores over time 6 months, 12 months and the independent variables included a treatment factor placebo, vitamin E and donepezila time factor 6 and 12 monthsand the treatment by time interaction.

It is performed by interviewing the patient to assess function and mental status and the informant, using a worksheet that comprehensively lists relevant symptoms potentially useful in judging clinically meaningful change, and allows for notes for future reference- it takes approximately 20 minutes per interview.

The coefficients for the LOCF analysis had the same directions as those of the coefficients in the above analysis. In particular, increases in CDR-sb scores that reflect clinical progression of disease severity without reference to baseline functioning were associated with increasing CGIC ratings, providing additional evidence for the validity of this CGIC rating approach in MCI.

National Center for Biotechnology InformationU. Downloads that will be available after satisfactory completion of the Request Form. Table 2 Analysis summary: Results were similar whether the 3-category or 2-category model was used Table 2Figure 1.

The GEE modeling framework was used to assess the impact of treatment hypothesis 1baseline covariates hypothesis 2 and change in clinical measures hypothesis 3 on the CGIC at 6 and 12 months based on the analyses of change patterns over these time intervals.